Barclays PLC Boosts Stock Position in Anavex Life Sciences

Dec 31, 2024 · Barclays PLC grew its holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) by 70.4% in the third quarter, according to its most recent disclosure with the …

4%
OFF

Barclays PLC Boosts Stock Position In Anavex Life Sciences

2 weeks from now

Dec 31, 2024 · Barclays PLC grew its holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) by 70.4% in the third quarter, according to its most recent disclosure with the …

marketbeat.com

7%
OFF

Anavex Life Sciences Corp (AVXL): …

2 weeks from now

1 day ago · Orion Capital Management LLC raised its holdings in shares of Anavex Life Sciences by 666.7% in the 3rd quarter. Orion Capital Management LLC now owns 11,500 shares of the …

advfn.com

4%
OFF

Anavex Life Sciences (NASDAQ:AVXL) Shares Gap Up After …

2 weeks from now

Dec 26, 2024 · Barclays PLC boosted its holdings in shares of Anavex Life Sciences by 70.4% during the 3rd quarter. Barclays PLC now owns 155,179 shares of the biotechnology …

americanbankingnews.com

4%
OFF

Barclays PLC Acquires 44,150 Shares Of Harvard Bioscience, Inc.

2 weeks from now

Jan 8, 2025 · Barclays PLC increased its holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO – Free Report) by 304.4% in the third quarter, according to its most recent Form 13F filing with …

americanbankingnews.com

4%
OFF

Anavex Life Sciences (NASDAQ:AVXL) Trading Down 11.3

2 weeks from now

Jan 8, 2025 · Barclays PLC grew its position in Anavex Life Sciences by 70.4% in the 3rd quarter. Barclays PLC now owns 155,179 shares of the biotechnology company's stock valued at …

marketbeat.com

5%
OFF

Barclays PLC Acquires 25,106 Shares Of Tyra ... - ETF Daily News

2 weeks from now

Dec 31, 2024 · Barclays PLC grew its holdings in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA – Free Report) by 200.5% during the third quarter, Holdings Channel reports. …

etfdailynews.com

12%
OFF

Barclays PLC Acquires 42,012 Shares Of Enliven Therapeutics, Inc ...

2 weeks from now

3 days ago · The institutional investor owned 56,217 shares of the company’s stock after purchasing an additional 42,012 shares during the quarter. Barclays PLC owned 0.12% of …

defenseworld.net

4%
OFF

Geode Capital Management LLC Increases Position In Anavex

2 weeks from now

Jan 1, 2025 · Barclays PLC raised its stake in Anavex Life Sciences by 70.4% in the third quarter. Barclays PLC now owns 155,179 shares of the biotechnology company's stock valued at …

marketbeat.com

1%
OFF

Barclays PLC Acquires 66,653 Shares Of Avid Bioservices, Inc.

2 weeks from now

3 days ago · Barclays PLC grew its holdings in shares of Avid Bioservices, Inc. (NASDAQ:CDMO – Free Report) by 98.1% in the third quarter, according to its most recent disclosure with the …

defenseworld.net

8%
OFF

Barclays PLC Acquires 35,750 Shares Of F&G Annuities

2 weeks from now

Dec 27, 2024 · Barclays PLC raised its holdings in shares of F&G Annuities & Life, Inc. (NYSE:FG - Free Report) by 527.8% during the third quarter, according to its most recent filing with the …

marketbeat.com

1%
OFF

Barclays PLC Acquires 100,498 Shares Of Wave Life Sciences

2 weeks from now

Dec 29, 2024 · Barclays PLC increased its stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 171.1% in the third quarter, according to the company in its most recent Form …

marketbeat.com

FAQs about Barclays PLC Boosts Stock Position in Anavex Life Sciences Coupon?

Does Barclays own ANAVEX life sciences (avxl)?

Barclays PLC raised its holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 70.4% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 155,179 shares of the biotechnology company’s stock after purchasing an additional 64,101 shares during the quarter. ...

Does Bank of New York Mellon own ANAVEX life sciences?

Bank of New York Mellon Corp now owns 280,556 shares of the biotechnology company’s stock valued at $1,184,000 after purchasing an additional 40,895 shares during the period. Finally, Rhumbline Advisers raised its position in Anavex Life Sciences by 15.8% in the second quarter. ...

Does Charles Schwab own ANAVEX life sciences?

Charles Schwab Investment Management Inc. raised its position in Anavex Life Sciences by 2.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 665,976 shares of the biotechnology company’s stock valued at $3,783,000 after purchasing an additional 14,892 shares during the period. ...

Who owns ANAVEX Life Sciences Corp (avxl) stock?

Hedge funds and other institutional investors own 31.55% of the company’s stock. AVXL stock opened at $11.04 on Tuesday. The company has a market capitalization of $936.37 million, a PE ratio of -22.08 and a beta of 0.73. Anavex Life Sciences Corp. has a 12-month low of $3.25 and a 12-month high of $14.44. ...

Did nwam buy ANAVEX life sciences?

Nwam LLC purchased a new stake in Anavex Life Sciences in the third quarter valued at $5,172,000. Charles Schwab Investment Management Inc. raised its position in Anavex Life Sciences by 2.3% in the third quarter. ...

Did Barclays PLC lift its holdings in Definitive Healthcare Corp?

Barclays PLC lifted its holdings in Definitive Healthcare Corp. (NASDAQ:DH – Free Report) by 318.8% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 81,916 shares of the company’s stock after purchasing an additional 62,354 shares during the period. ...